Skip to content

Testing for HIV should no longer be accorded special status, says BMJ editorial

CDC pioneers family-based "preventive care" in Uganda as framework for rollout

Two new formulations receive European go-ahead

Fibrosis progression may be faster than expected in HCV/HIV-coinfected patients

Tenofovir at least equivalent to adefovir for treatment of hepatitis B in HIV-infected patients

Is less than 95% adherence to NNRTIs good enough to lead to viral suppression?

Tipranavir superior to other PIs in detailed resistance analysis

Entecavir gains ground as anti-HBV option in HIV-coinfected patients

TMC114 appears to be strong PI option for salvage therapy